Table S6 from Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations

Rong Zhou,Chaoji Shi,Wenjie Tao,Jiang Li,Jing Wu,Yong Han,Guizhu Yang,Ziyue Gu,Shengming Xu,Yujue Wang,Lizhen Wang,Yanan Wang,Guoyu Zhou,Chenping Zhang,Zhiyuan Zhang,Shuyang Sun

DOI: https://doi.org/10.1158/1078-0432.22475268.v1

2023-01-01

Abstract:Supplementary figures and figure legends. (Figure S1) Deregulation of genes within key affected signaling pathways in MM. (Figure S2) Validation of the somatic SNV/InDels found in POM121. (Figure S3) Copy number changes in MM. (Figure S4) Distribution of SVs and genetic events including breakage-fusion-bridges [BFBs] and chromothripsis across chromosomes among all samples. (Figure S5) Validation of SV occurring between chromosome 5 and 12 in MM023 and MM065. (Figure S6) Fine structure of BFBs and chromothripsis found in MM. (Figure S7) Comparison of lesions found in mucosal melanoma. (Figure S8) Validation of the copy number alteration of CDK4 and TERT in representative samples. (Figure S9) FISH confirming amplification and co-localization of CDK4 [12q14] and TERT [5p15]. (Figure S10) Molecular characterization of the MM PDX models and the effects of palbociclib on Rb phosphorylation in treatment-responsive PDX models. (Figure S11) Significant mutated non-coding region genes in MMs. (Figure S12) Mutation signatures found in MM.